Vsee Health, INC

VSEE Health, Inc. has entered into a settlement agreement to resolve disputes with ADI Funding LLC and M2B Funding Corp., involving repayment of existing debt, issuance of new promissory notes, and restricted shares.

VSee Health, Inc. has announced its 2026 Annual Meeting of Stockholders will be held on August 25, 2026, with July 6, 2026, set as the record date.

VSEE Health, Inc. has entered into two separate agreements to issue convertible notes totaling $575,550, providing capital for general working purposes.

VSee Health, Inc. has received a notice of default from ADI Funding, LLC regarding a $271,739.13 secured promissory note.

VSee Health, Inc. has entered into a securities purchase agreement to issue a secured promissory note to an institutional investor, ADI Funding LLC, for $271,739.13.

VSee Health, Inc. has entered into a Standby Equity Purchase Agreement with YA II PN, LTD. for up to $10 million in common stock.

VSee Health reports a net loss of $2.6 million for Q1 2026 amid ongoing liquidity challenges and material weaknesses in internal controls.

VSee Health reported a 1050% increase in net loss to $6.57 million for the first half of 2025 despite a 101% revenue surge, driven by higher operating expenses and fair value losses on financial instruments.

VSee Health, Inc. reported a 60% revenue increase for the nine months ended September 30, 2025, driven by its iDoc acquisition, but faces substantial doubt about its ability to continue as a going concern due to persistent operating losses and liquidity challenges.

VSee Health, Inc. reported a significant 1050% increase in net loss for Q2 2025, raising substantial doubt about its ability to continue as a going concern amidst internal control weaknesses and ongoing financing needs.

VSee Health, Inc. reported a significant net loss of $3.96 million in Q1 2025, despite a 105% revenue increase, raising substantial doubt about its ability to continue as a going concern.

VSee Health's Q3 2024 results show a significant net loss due to a large goodwill impairment charge, despite revenue growth driven by recent acquisitions.

VSee Health, Inc. reported a 40% revenue increase in 2025 but faces substantial doubt about its ability to continue as a going concern, coupled with Nasdaq minimum bid price non-compliance and material internal control weaknesses.

VSee Health, Inc. filed an amended annual report for 2024, restating prior financials, reporting a significant net loss driven by goodwill impairment, and disclosing substantial doubt about its ability to continue as a going concern.

VSee Health, Inc. reported a net loss of over $57 million for 2024, driven by significant goodwill impairment and financial restatements, raising substantial doubt about its ability to continue as a going concern.

Digital Health Acquisition Corp.'s annual 10-K filing details the company's registered securities, including units, common stock, and warrants, as of December 31, 2023.

VSEE Health's CFO, Jerry Leonard, acquired common stock through quarterly equity awards, resulting in a net change in his beneficial ownership.

VSEE Health's Co-CEO, Imoigele Aisiku, increased beneficial ownership by 288,410 shares through quarterly equity awards, reflecting a significant decline in the company's stock price during 2025.

VSEE Health, Inc. Director Colin P. O'Sullivan acquired 40,107 shares of common stock at $0.374 per share, increasing his direct beneficial ownership to 108,731 shares.

VSEE Health Director Scott Metzger acquired 40,107 shares of common stock as compensation for services rendered, increasing his direct beneficial ownership to 117,356 shares.

VSEE Health Director Kevin Lowdermilk acquired 40,107 shares of common stock as part of his compensation for Q4 2025 services.

VSEE Health Director David L. Wickersham acquired 40,107 shares of common stock as part of his compensation for services.

VSee Health, Inc. is holding its annual stockholder meeting on August 25, 2026, to vote on director elections, auditor ratification, a reverse stock split, and adjournment.

VSee Health, Inc. is holding a special meeting to seek stockholder approval for the issuance of common stock related to a recent private placement, as required by Nasdaq listing rules.

VSEE Health, Inc. has amended its bylaws to reduce the quorum requirement for its Annual Meeting of Stockholders to one-third of voting power and engaged a proxy advisor.

VSee Health, Inc. will hold its Annual Meeting on December 15, 2025, to vote on director elections, auditor ratification, and a new equity incentive plan, amidst disclosures of financial difficulties and deferred executive salaries.

VSee Health is registering over 33.8 million shares for resale by selling stockholders, while its auditors express substantial doubt about the company's ability to continue as a going concern.

VSee Health, Inc. has filed an amendment to its S-1 registration statement to allow for the resale of up to 4,495,119 shares of common stock by selling stockholders.

VSee Health is registering for resale up to 4,495,119 shares of its common stock by selling stockholders, primarily from convertible notes and warrants.

VSee Health, Inc. files an amendment to its S-1 registration statement primarily to include exhibits related to an equity purchase agreement and commitment note.

VSee Health is registering up to 36,550,000 shares of common stock, including those issuable upon warrant exercises and potential sales to Dominion Capital LLC.

VSee Health, Inc. has filed a registration statement for the issuance of shares upon warrant exercise and resale of shares by Dominion Capital LLC, potentially raising up to $90 million.

Lawrence Sands and affiliated entities filed an amended Schedule 13D, detailing their beneficial ownership of VSee Health, Inc. common stock and recent distributions.

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 9.99% of VSee Health, Inc. common stock as of March 31, 2026.

Alta Partners, LLC and Steven Cohen have disclosed a 2.0% beneficial ownership stake in VSee Health, Inc., primarily through warrants and a warrant exchange agreement.

Dominion Capital Group and its affiliates have filed an exit Schedule 13G, reporting their beneficial ownership in VSEE Health, Inc. has fallen below 5%.

Alta Partners, LLC and Steven Cohen report a 9.5% beneficial ownership stake in VSee Health, Inc., primarily through warrants and a warrant exchange agreement.

A group of investors, including Dominion Capital and Ascent Partners, has disclosed a 9.9% beneficial ownership stake in VSEE Health, Inc. through a Schedule 13G filing.